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Spasticite´ (II) / Revue d’E´pide´miologie et dee332Methodology.– Review of scientific societies recommendations on the
implementation of loco-regional anesthetic blocks for optimal security of
these gestures in the PMR care units.
Results.– The gesture in PRM is primarily concerned with the effects of
selective motor blocks to analyze the function (walking, grip), sensory nerve
blocks provide to analyze muscle-tendon length in order to surgery or finally
for anesthesia to produce botulinum toxin in good conditions. The choice of the
pharmacologic agents is related to the duration and onset of action, its power
and its toxicity. In PRM, the ropavicaine (long time and action) and lidocaine
(short time and action) are the most used. The risk of toxicity is related to
systemic leakage of the drug (cardiac and neurological toxicity proportional to
the concentration of pharmacologic anesthetic medication), or immuno-
allergic phenomena, which are very rare (anaphylaxis). Other complications
are related to material tracking nerve fibers (neuro-stimulators, short bevel
needle) and the technique performed poorly can cause sores and residual
neuropathic pain.
Discussion.– The indications for anesthetic block in PMR are essentially
peripheral nerve (not central) with uni- or multishots. It has three advantages:
functional and/or orthopedic assessment or distal anesthesia. Nerve block in
‘‘one shot’’ is somewhat risky given the tolerance of the products and the
injected volume of less than 6 cm3 (allergic risk wound and neuropathic pain).
‘‘Multiple shots’’ nerve blocks require knowledge of the risk of systemic
anesthetic drug leakage (initially neurological toxicity then cardio-circulatory).
The amount of anesthetic drugs must not exceed 30 cm3, appropriate
monitoring, the availability of an intravenous line, resuscitation equipment
for treatment without delay, a certificate of competence to care emergency.
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Introduction.– Tibial neurotomy is the surgical treatment of choice in case of
spastic equinovarus foot without associated musculo-tendinous shortening. In
order to confirm the surgical indication, diagnostic nerve block with
anaesthetics of the tibial motor nerve branches are usually recommended.
Objective.– To compare the improvement observed after diagnostic block and
after tibia neurotomy in case of spastic equinovarus foot in hemiplegic patients.
Material and methods.– This prospective study evaluated 30 hemiplegic
patients who benefited from diagnostic nerve block and tibial neurotomy with a
2 years follow-up. Triceps spasticity (Ashwoth scale), tibialis anterior muscle
strength (MRC scale), passive ankle dorsiflexion, gait parameters (10 meters
walking test) and gait kinematics (video analysis) were assessed before and
after diagnostic nerve block and 2 months and 2 years after selective tibial
neurotomy.
Results.– The decrease in spasticity and the improvement in equinovarus
deformity were similar after the diagnostic nerve block and 2 months and 2
years after neurotomy. The diagnostic nerve block did not reveal the slight
increase in gait speed and in tibialis anterior muscle strength that was observed 2
years after neurotomy. No limitation of the passive ankle dorsiflexion was
observed.
Conclusion.– The diagnostic nerve block with anaesthetics predict the decrease
in spasticity and the improvement in gait kinematics observed after tibial
neurotomy in case of spastic equinovarus foot. We recommended the use of this
diagnostic tool, which also allows the patient to feel what could be the benefit
from a neurotomy.
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Objectives.– The claw toe is a common and disabling in patients with
hemiplegia. Unfortunately in France, there are no recommendations or
consensus on its treatment. The objective of this work is to offer therapists a grid
to facilitate consensus decision-making in the management of neurologic claw
toes.
Method.– Initially, we constructed a guideline on the treatment of neurologic claw
toes by synthesizing the literature data and service experience of PMR of
Toulouse. Then, we evaluate this guideline by national medical experts in this
field, to propose a consensual decision-making grid. The evaluation concerned,
first, the overall quality of the guideline especially the realisation of a nerve block
to xylocaine prior to completion of an injection of botulinum toxin. Then, through
participation of the intrinsic muscles in the claw, as evidenced by a positive block
of the posterior tibial nerve at the ankle, selection of the muscle to inject was
performed: flexor digitorum brevis or quadratus plantae. Finally, the prescription
of treatment by orthopedic insoles retrocapital support was discussed.
Results.– This survey has generated a real interest from experts contacted with a
response rate of 100% in a very short time. Overall, this grid is shared by most
experts, from which evaluates its usefulness to 6/10. They offer mainly
treatment retrocapital soles with support and often do not perform nerve block
before inject toxin. Moreover, in case of participation of the intrinsic muscles in
the claw, they are more accustomed to inject muscle flexor digitorum brevis.
Discussion.– The completion of this investigation has raised the problem of
blocks considered by ASFAR as acts of anesthesia, while many PMR do in their
service. Finally, from a methodological standpoint, it would be interesting to
repeat this process to facilitate the management of the main weaknesses of
hemiplegics patients as stiff-knee or equinovarus.
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Purpose.– To demonstrate the efficacy of the selective neurotomy in treating
spastic equinovarus foot (SEF) in adult stroke patients.
Material and methods.– Sixteen chronic stroke patients were recruited and
randomised in two groups: eight patients underwent a tibial neurotomy, the
eight others received botulinum toxin injections in the calf muscles. Body
structures and functions (MAS, Tardieu scale, L-path, MRC scale, passive
ROM, instrumented gait analysis), activities (ABILOCO), participation
(SATIS-Stroke) and quality of life (SF-36) were evaluated in both groups by
a blind assessor before, 2 months and 6 months after treatment.
Results.– In comparison with botulinum toxin injections, tibial nerve neurotomy
induced a higher reduction in spasticity and a more significant decrease in total
viscoelastic stiffness of the ankle. Both treatments induced a comparable
improvement of ankle kinematics during gait, while none of them induced a
significant muscle weakening. Activities, participation and quality of life were
not significantly modified in both groups.
Sante´ Publique 55S (2012) e329–e334
Spasticite´ (II) / Revue d’E´pide´miologie et deDiscussion.– SEF is a major cause of disability for stroke patients, impairing
their daily living activities, social participation and quality of life. When this
deformity is primarily due to muscle overactivity, various focal treatments
including selective neurotomy can be proposed together with the rehabilitation
program. This neurosurgical procedure consists of a partial and selective section
of the motor nerve branches that innervate spastic muscles. For a low cost, it can
permanently reduce muscle overactivity. However, its effectiveness had only
been suggested through uncontrolled case series studies [1], mainly focussing
on body structures and functions.
The present study demonstrates with a high level of scientific evidence that
tibial nerve neurotomy is an efficient treatment of SEF, reducing impairments of
chronic stroke patients. Future studies should still be conducted in order to
confirm the long-term efficacy of this treatment following the International
Classification of Functioning, Disability and Health (ICF).
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Objective.– To study the interest of the use of an anesthetic cream in prevention of
the pain during the injections of botulinum toxin at the child and the teenager.
Method.– The evaluation is realized in two populations of cerebral palsy
children and teenagers. A population receives the application of anesthetic
cream before the injections. Other population is injected without anesthetic
cream. The pain is estimated by a score EVA or a scal of CHEOPS according to
the capacities of the patient. The ‘‘reactivity’’ is appreciated in ‘‘important,
average, low, no’’.
In 2011, we presented a preliminary study but series, too small did not allow a
statistical study.
Results.– We have 193 medical records. The clinical forms were variable
(classification GMFCS). Ninety-seven were evaluated their pain on an EVA, 96
other, are estimated by the CHEOPS. Ninety-six had received anesthetic cream,
97 were injected without. Two populations were homogeneous. The average of
EVA is 2,9 with the cream 2 without. The average of CHEOPS is 7 with the
cream, 7,2 without. We also analyze the results according to the age, to the
number of muscles, concerned limbs or an adjuvating treatment.
Discussion.– Other factors such as the waiting time before injection is probably
involved in the patient’s anxiety.
The passage of the skin seems to us also less painful since we use the electric
stimulation, the needles being finer.
It is more often to the injection of the product than to the passage of the skin that
the child reacts.
Conclusion.– This work does not justify the usefulness of applying an anesthetic
cream prior to injections of botulinum toxin in cerebral palsy children and
adolescents to decrease the pain induced.
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Introduction.– Intrathecal baclofen is known as an effective treatment of
muscular hypertonia in chronic stages of vascular or traumatic brain damaged
subjects [1]. Its interest in early management is supported by its effects on
neurovegetative crisis [2].
Materials and methods.– A 61-year-old female patient in persistent vegetative-
nervous state two months after a bilateral anterior cerebral artery stroke,
presented with spastic tetraplegia and equine retracted feet despite an optimal
antispastic treatment (oral treatment and botulinum toxin injections).
Considering a global muscle hypertonia with a mean score (MAS) of 3.8 on
inferior limbs and 3 on superior limbs, and after positive intrathecal baclofen
test, pump implantation was decided on day 90 after stroke.
Results.– An improvement of hypertonia of 2 points (MAS) on inferior limbs
and of 1.4 on superior limbs facilitating the patient’s nursing and bed
positioning, as well as an improvement of WHIM of 21 points were noted one
week after treatment. No complication was reported.
Discussion.– A diffuse muscle hypertonia with secondary neuro-orthopedic
complications can appear in early stages after a severe brain damage. Our case
emphasizes the importance of screening and early management of those muscle
tonus troubles, with particular interest in early intrathecal baclofen treatment.
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Objective.– To describe the adverse events (AE) occurring after intrathecal
baclofen (ITB) pump placement.
Patients and methods.– We prospectively collected all the AE occurring in
patients receiving ITB via a pump, from the rehabilitation setting of R.-Poincaré
Hospital during 2010.
Results.– 158 patients were enrolled, mean age 46 years and 65% male. 128
patients were former implanted (FI) and 30 had a pump placement during 2010:
20 new-implanted (NI) and 10 replacements (R). Most of patients were SCI
patients (44 paraplegic and 23 tetraplegic) and MS patients (45). 18% of the
patients had one or more complications (38 complications). For a total follow-
up of 1665 months, there were 0,023 complications per pump-month.
Sante´ Publique 55S (2012) e329–e334 e333
